On April 26th, CHC Medical Consulting and CITIC Securities officially released the "2022 China Medical and Health Industry Investment and Financing Honor List". Guangdong Pulse Medical Technology Co., Ltd. has added new reputation with its outstanding performance in 2022, and has been honored to be listed as the most influential enterprise in medical and health for the year.
The "China Medical and Health Industry Investment and Financing Honor List" is jointly launched by CHC Medical Consulting and CITIC Securities. Through data statistics, horizontal comparison, and comprehensive analysis, it selects investment institutions, investors, innovative enterprises and other industry participants who have made outstanding contributions in the development and investment and financing of the medical and health industry in the previous year, recognizes their value contributions, and sets industry benchmarks. Through five years of deep cultivation, the Honor List selection has become one of the important indicators for the development and investment and financing of China's medical and health industry.
2022 is a year full of ups and downs, and the medical and health industry has undergone the most rigorous tests. Pulse Medical is going against the current and standing at the forefront. We focus on technology and take "innovation" as the propeller; We have sharp eyes and sail with 'value'.
In 2023, we will usher in a truly 'post pandemic era', especially after the National People's Congress and the Chinese People's Political Consultative Conference. Market confidence will be boosted, industry vitality will be stimulated, and the medical and health industry will once again become the focus of market attention. As the industry accelerates again and is inspired by another new honor, Pulse Medical, as a high-tech medical enterprise that always adheres to the principle of "patient first" service, will continue to serve the vast number of patients and medical staff with high-quality products and excellent technology.